HCW Biologics Inc. (HCWB)
NASDAQ · Manufacturing · Pharmaceutical preparations
HCWB price, last 12 months
Key stats
- Previous close
- $1.99
- Open
- $1.88
- Day range
- $1.81 – $2.00
- 52-week range
- $1.50 – $29.28
- Volume
- 418.8K
- Avg volume (20 days)
- 963.1K
- Market cap
- $3.5M
Performance
Technicals and fundamentals
About HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $3.5M